Methyl (2S,3R,4S)-2-(beta-D-glucopyranosyloxy)-4-{2-[(3,4,5-trihydroxybenzoyl)oxy]ethyl}-3-vinyl-3,4-dihydro-2H-pyran-5-carboxylate(CAS: 131189-57-6)
![Methyl (2S,3R,4S)-2-(beta-D-glucopyranosyloxy)-4-{2-[(3,4,5-trihydroxybenzoyl)oxy]ethyl}-3-vinyl-3,4-dihydro-2H-pyran-5-carboxylate Methyl (2S,3R,4S)-2-(beta-D-glucopyranosyloxy)-4-{2-[(3,4,5-trihydroxybenzoyl)oxy]ethyl}-3-vinyl-3,4-dihydro-2H-pyran-5-carboxylate](https://cnstatic.chemtradehub.com/structs/131/131189-57-6-0085.webp)
CAS号
相关产品
其他供应商提供的 Methyl (2S,3R,4S)-2-(beta-D-glucopyranosyloxy)-4-{2-[(3,4,5-trihydroxybenzoyl)oxy]ethyl}-3-vinyl-3,4-dihydro-2H-pyran-5-carboxylate
基本信息
分子式
C24H30O14
分子量
542.49 g/mol
物理状态
Powder
化学标识符
SMILES
COC(=O)C1=COC(C(C1CCOC(=O)C2=CC(=C(C(=C2)O)O)O)C=C)OC3C(C(C(C(O3)CO)O)O)O
InChIKey
SMTKSCGLXONVGL-UPIRYGIPSA-N
数据库引用
MDL号
MFCD21606970
常见问题
山茱萸新苷为白色至浅黄色结晶性粉末,分子量约为630.16。该化合物在水中的溶解度较低,在乙醇中具有较好的溶解性。在化学反应中,山茱萸新苷显示出较强的亲核性,对亲电试剂具有一定的反应活性。它在碱性条件下易发生水解反应,在酸性条件下可发生酯交换反应。
山茱萸新苷通常通过天然产物提取、化学合成或半合成方法获得。其合成方法包括但不限于:利用葡萄糖衍生物与苯甲酸衍生物进行缩合反应,随后通过环化、酯化等步骤得到目标化合物。该过程可能需要使用到催化剂如酸或碱,并且产率一般可达到50%-60%。
山茱萸新苷主要应用于医药行业,作为中药成分用于开发治疗心血管疾病、抗炎和抗氧化的药物。此外,它也可能应用于食品添加剂行业,作为天然甜味剂或抗氧化剂。
处理山茱萸新苷时应佩戴适当的个人防护装备,如手套、护目镜和实验服。操作应在通风橱中进行,避免吸入该化合物的粉尘和蒸汽。如发生泄漏,应立即清理并使用适当的吸收剂,避免直接接触皮肤或眼睛。参考安全数据表(SDS)获取更详细的安全信息。
安全须知
使用前请验证产品规格和安全数据。联系供应商获取详细安全信息。
请始终遵循正确的操作程序

![(6aR)-1,2-Dimethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline](https://cnstatic.chemtradehub.com/structs/475/475-83-2-566d.webp)
![(14S,27R)-22,33-Dimethoxy-13,28-dimethyl-2,5,7,20-tetraoxa-13,28-diazaoctacyclo[25.6.2.2~16,19~.1~3,10~.1~21,25~.0~4,8~.0~14,39~.0~31,35~]nonatriaconta-1(33),3,8,10(39),16,18,21(36),22,24,31,34,37-dod
ecaene](https://cnstatic.chemtradehub.com/structs/481/481-49-2-d49c.webp)

![(1S,2R,4R,5R,6S,8R,10S,11S,12R,14R,15R,16R,19S,21R)-6-(3-Furyl)-12,16,19-trihydroxy-5,11,15-trimethyl-3-oxo-9,17-dioxahexacyclo[13.3.3.0~1,14~.0~2,11~.0~5,10~.0~8,10~]henicosane-4,21-diyl diacetate](https://cnstatic.chemtradehub.com/structs/588/58812-37-6-c4a7.webp)

![(2R,3R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy-2,3-dihydrochromen-4-one](https://cnstatic.chemtradehub.com/structs/572/572-31-6-efe4.webp)
![(3β,25S)-Spirost-5-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1→2)-O-[β-D-xylopyranosyl-(1→3)]-β-D-glucopyranoside](https://cnstatic.chemtradehub.com/structs/874/87480-46-4-e9d4.webp)


![Methyl (2S,3R,4S)-2-(beta-D-glucopyranosyloxy)-4-{2-[(3,4,5-trihydroxybenzoyl)oxy]ethyl}-3-vinyl-3,4-dihydro-2H-pyran-5-carboxylate — 上海绩祥生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ce6f4d2b2de6e8e95a45bf/67ce6f4d2b2de6e8e95a45bf-logo.webp)
![Methyl (2S,3R,4S)-2-(beta-D-glucopyranosyloxy)-4-{2-[(3,4,5-trihydroxybenzoyl)oxy]ethyl}-3-vinyl-3,4-dihydro-2H-pyran-5-carboxylate — 上海融禾医药科技发展有限公司](https://cnstatic.chemtradehub.com/suppliers/67ced5562b2de6e8e95a722d/67ced5562b2de6e8e95a722d-logo.webp)
![Methyl (2S,3R,4S)-2-(beta-D-glucopyranosyloxy)-4-{2-[(3,4,5-trihydroxybenzoyl)oxy]ethyl}-3-vinyl-3,4-dihydro-2H-pyran-5-carboxylate — 南京清韵生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67ceccda2b2de6e8e95a5ddc/67ceccda2b2de6e8e95a5ddc-logo.webp)
![Methyl (2S,3R,4S)-2-(beta-D-glucopyranosyloxy)-4-{2-[(3,4,5-trihydroxybenzoyl)oxy]ethyl}-3-vinyl-3,4-dihydro-2H-pyran-5-carboxylate — 上海羽朵生物科技有限公司](https://cnstatic.chemtradehub.com/suppliers/67cecd502b2de6e8e95a5ee5/67cecd502b2de6e8e95a5ee5-logo.webp)